Corpus Intelligence IC Memo — OSF HEALTHCARE TRANSITIONAL CARE HOS 2026-04-26 08:02 UTC
IC Memo — OSF HEALTHCARE TRANSITIONAL CARE HOS
Investment Committee Memorandum | IL | 18 beds | Grade C | EBITDA uplift $1.7M
🛡️ Public data only — no PHI permitted on this instance.
Investment Committee Memorandum

OSF HEALTHCARE TRANSITIONAL CARE HOS

CCN 142013 | PEORIA, IL | 18 beds | April 26, 2026
EBITDA BridgeData Room
C
Investability

1. Target Overview & Investment Thesis

OSF HEALTHCARE TRANSITIONAL CARE HOS is a 18-bed under-performing / distressed in PEORIA, IL with $22.9M in net patient revenue and a -38.6% operating margin. The hospital serves a payer mix of 30.0% Medicare, 0.2% Medicaid, and 69.8% commercial.

Thesis: Turnaround. Our ML models identify $1.7M in annual EBITDA improvement potential from RCM optimization across 5 levers, lifting margin from -38.6% to -31.3% (+736bps).

Net Revenue HCRIS$22.9M
Current EBITDA COMPUTED$-8.8M
Operating Margin COMPUTED-38.6%
Occupancy HCRIS80.3%
Revenue / Bed COMPUTED$1.3M
Net-to-Gross HCRIS31.1%
Distress Probability ML40.1%

2. Market Context & Competitive Position

208
IL Hospitals
-5.3%
State Median Margin
59
Comparable Hospitals

IL has 208 Medicare-certified hospitals with a median operating margin of -5.3%. The target's margin of -38.6% places it below the state median. Among 59 size-comparable peers (9-36 beds), the median margin is -0.8%. The target's below-peer margin suggests operational improvement opportunity.

3. RCM Performance Analysis — Comparable Hospitals

Comps selected by bed count (9-36), prioritizing same-state peers. 59 hospitals in the comp set.

HospitalStateBedsRevenueMargin
OSF HEALTHCARE TRANSITIONAL CA (Target)IL18$22.9M-38.6%
GIBSON AREA HOSPITAL AND HEALTIL25$125.0M-6.7%
PARIS COMMUNITY HOSPITALIL25$100.7M-4.2%
SAINT JOSEPH MEMORIAL HOSPITALIL25$86.0M33.9%
WABASH GENERAL HOSPITALIL25$71.8M4.5%
HOOPESTON COMMUNITY MEMORIAL HIL22$71.5M-5.2%
CRAWFORD MEMORIAL HOSPITALIL25$67.7M2.9%
ST. FRANCIS HOSPITALIL25$61.6M17.4%
LINCOLN MEMORIAL HOSPITALIL25$61.5M14.8%

4. Predicted Improvement Opportunities

Improvement targets set at P75 of comparable peers with 60% gap closure assumption. Coefficients calibrated to published research bands. Total EBITDA uplift: $1.7M (736bps margin improvement).

LeverCurrentTargetEBITDA ImpactMarginRamp
Net Collection Rate93.5%97.0%$480K+210bp18mo
Cost to Collect4.5%2.5%$457K+200bp12mo
Denial Rate Reduction12.0%6.5%$453K+198bp12mo
A/R Days Reduction5200.0%3800.0%$278K+122bp9mo
Clean Claim Rate88.0%96.0%$15K+6bp6mo

5. EBITDA Bridge

Net Collection Rate
$480K
Cost to Collect
$457K
Denial Rate Reduction
$453K
A/R Days Reduction
$278K
Clean Claim Rate
$15K
Total EBITDA Uplift$1.7M
Current EBITDA$-8.8M
+ RCM Uplift+$1.7M
Pro Forma EBITDA$-7.1M
Current Margin-38.6%
Pro Forma Margin-31.3%
WC Released (1x)$877K

6. Returns Analysis — Scenario Matrix

5-year hold, 5.5x leverage, 3% organic growth, 10%/yr debt paydown. Base case uses 100% of predicted RCM uplift. Bull case: 130% uplift at lower entry. Bear case: 50% uplift at higher entry.

ScenarioEntryExitEquity InEquity OutMOICIRR
Base Case10.0x10.0x$-13.6M$-41.4M0.00x-100.0%
Base (11x exit)10.0x11.0x$-13.6M$-50.0M0.00x-100.0%
Bull Case9.0x11.0x$-12.2M$-48.8M0.00x-100.0%
Bull (12x exit)9.0x12.0x$-12.2M$-56.9M0.00x-100.0%
Bear Case11.0x10.0x$-14.9M$-45.4M0.00x-100.0%
Bear (11x exit)11.0x11.0x$-14.9M$-54.8M0.00x-100.0%

7. Key Risks & Mitigants

SeverityRisk FactorMitigant
HighNegative operating marginRCM uplift bridge shows clear path to profitability; working capital release provides near-term cash cushion

8. Data Sources & Methodology Appendix

Data Sources

  • CMS HCRIS Cost Reports (Medicare-certified hospitals)
  • CMS Medicare Utilization (DRG-level volumes)
  • CMS Chronic Conditions (county-level disease prevalence)
  • HCRIS multi-year trend data (financial time series)

Comparable Selection

  • 59 hospitals with 9-36 beds
  • Same-state prioritization (n=60)
  • Comp margins: P25=-6.0% / P50=-0.8% / P75=7.8%

Bridge Methodology

  • Targets: P75 of comparable peers (60% gap closure)
  • Denial: avoidable share = 35% of delta × NPR
  • AR: bad debt coefficient = $0.65 per day per $1K NPR
  • NCR: 60% coefficient on collection rate improvement
  • CDI: 0.75% of Medicare revenue per 0.01 CMI point

Returns Assumptions

  • Leverage: 5.5x entry (84.6% debt / 15.4% equity)
  • Organic growth: 3% annual EBITDA growth
  • Debt paydown: 10% of principal per year
  • Hold period: 5 years

Generated by SeekingChartis on April 26, 2026. All predictions use public data only. Confidence intervals calibrated via split conformal prediction (90% coverage target). This memo is for informational purposes and does not constitute investment advice.